This might be especially important in the context of EC metabolism (an emerging target of AAT), as recent reports documented that ECs reprogram their metabolism and metabolic transcriptome in pathological conditions such as cancer and ocular disease14,19,20. This evidence concerns the gene SERPINA1 and cancer.